Patient anatomy-specific trade-offs between sub-clinical disease coverage and normal tissue dose reduction in head-and-neck cancer. Patricia Kaplan L, Ivalu Sander Holm A, Grau Eriksen J, Heijmen BJM, et al. Radiother Oncol 2023 Feb 8:109526. doi: 10.1016/j.radonc.2023.109526.

Read + Share

Amedeo Smart

Independent Medical Education

Patricia Kaplan L, Ivalu Sander Holm A, Grau Eriksen J, Heijmen BJM, et al. Patient anatomy-specific trade-offs between sub-clinical disease coverage and normal tissue dose reduction in head-and-neck cancer. Radiother Oncol 2023 Feb 8:109526. doi: 10.1016/j.radonc.2023.109526.
PMID: 36764458